Catalog No.
RVV02809
Expression system
Mammalian Cells
Species reactivity
Human respiratory syncytial virus A (strain A2)
Host species
Human
Isotype
IgG1, kappa
Clonality
Monoclonal
Target
F, Fusion glycoprotein F0, Protein F, CR9515,RSV
Concentration
1.18 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03420
Applications
FCM, Neutralization
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
D25
Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice. [RVV02809]
Development of a genetically modified full-length human respiratory syncytial virus preF protein vaccine. [RVV02809]
Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response., PMID:33574352
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection., PMID:29029312
Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic., PMID:11277694
Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage., PMID:1375280
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization., PMID:2251875
For research use only. Not for human or drug use.
